Evidence map›Paper›PMID 34912781›Full record

ArticleFrontiers in chemistry2021

Synthesis and Discovery of Schiff Base Bearing Furopyrimidinone for Selective Recognition of Zn

Yanggen Hu, Chao Luo, Lili Gui, Jing Lu, Juncai Fu, Xinya Han, Junkai Ma, Lun Luo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yanggen HuHubei Key Laboratory of Wudang Local Chinese Medicine, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, China.
Chao LuoInstitute of Biomedicine, Hubei University of Medicine, Shiyan, China.
Lili GuiHubei Key Laboratory of Wudang Local Chinese Medicine, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, China.
Jing LuHubei Key Laboratory of Wudang Local Chinese Medicine, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, China.
Juncai FuThe First Clinical College, Hubei University of Medicine, Shiyan, China.
Xinya HanDepartment of Chemical Biology and Pharmaceutical Engineering, School of Chemistry and Chemical Engineering, Anhui University of Technology, Shiyan, China.
Junkai MaHubei Key Laboratory of Wudang Local Chinese Medicine, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, China.
Lun LuoHubei Key Laboratory of Wudang Local Chinese Medicine, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, China.
Hubei University of Medicine · CNAnhui University of Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A simplefuro [2,3-d]pyrimidinone-based Schiff base FPS was synthesized via aza-Wittig reaction and structure elucidation was carried out by spectroscopic studies FT-IR, 1H NMR, and 13C NMR and mass spectrometry. FPS showed weak fluorescence emission in methanol and the selectivity of FPS to different metal ions (Mn

Indexed as

Cu2+/Fe2+ detectionfluorescencefuro[2, 3-d]pyrimidinonelive cells imagingschiff baseZn2+ recognition

Identifiers

PMID34912781
PMCPMC8666604
OpenAlexW3216370106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.